These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 4467054)

  • 21. Dose related blood pressure response and plasma propranolol levels in essential hypertension.
    Som C; Bhattacharya SK; Singh NK; Gode KD
    Indian Heart J; 1984; 36(1):20-2. PubMed ID: 6706361
    [No Abstract]   [Full Text] [Related]  

  • 22. [Treatemtn of arterial hypertension with the combination of hydralazine and propranolol].
    Sabbaga E; Chocair PR; Ianhez LE; Massola VC
    Rev Paul Med; 1974 Mar; 83(3):97-100. PubMed ID: 4445688
    [No Abstract]   [Full Text] [Related]  

  • 23. Practolol-propranolol. A comparison of antihypertensive effect.
    Andersson O; Berglund G
    Acta Med Scand; 1974 Dec; 196(6):479-82. PubMed ID: 4617491
    [No Abstract]   [Full Text] [Related]  

  • 24. Long-term experience of spironolactone in essential hypertension.
    Jeunemaitre X; Kreft-Jais C; Chatellier G; Julien J; Degoulet P; Plouin PF; Ménard J; Corvol P
    Kidney Int Suppl; 1988 Oct; 26():S14-7. PubMed ID: 3199684
    [No Abstract]   [Full Text] [Related]  

  • 25. [The effect of spironolactone and trichlormethiazide on blood pressure, plasma dry weight and plasma potassium in the elderly hypertension].
    Nakada I; Sekimoto H; Nakano T; Shimada O; Horibe N; Fuse N
    Nihon Ronen Igakkai Zasshi; 1983 Nov; 20(6):491-9. PubMed ID: 6371331
    [No Abstract]   [Full Text] [Related]  

  • 26. [Mechanism of the antihypertensive action of propranolol].
    Magnani B; Ambrosioni E; Branzi A; Maresta A; Picchio F; Russo F; Sanguinetti M
    Minerva Cardioangiol; 1973 Apr; 21(4):284-97. PubMed ID: 4710125
    [No Abstract]   [Full Text] [Related]  

  • 27. [Treatment of essential hypertension with spironolactone with reference to the plasma renin activity].
    Esch I; Placheta P
    Wien Klin Wochenschr; 1973 Jun; 85(23):413-7. PubMed ID: 4575841
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effectiveness of propranolol in the treatment of arterial hypertension in elderly patients].
    Halawa B
    Przegl Lek; 1984; 41(8):545-50. PubMed ID: 6393225
    [No Abstract]   [Full Text] [Related]  

  • 29. ["Crossover" double-blind study on the antihypertensive effect of propranolol and practolol].
    Distler A; Krönig B; Schumann G; Walter B
    Verh Dtsch Ges Inn Med; 1975; 81():1042-4. PubMed ID: 1229393
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparison of chlorthalidone and spironolactone in low--renin essential hypertension.
    Kreeft JH; Larochelle P; Ogilvie RI
    Can Med Assoc J; 1983 Jan; 128(1):31-4. PubMed ID: 6336600
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spiroprop (spironolactone + propranolol) for hypertension.
    Drug Ther Bull; 1985 Apr; 23(8):31-2. PubMed ID: 3996214
    [No Abstract]   [Full Text] [Related]  

  • 32. [Prevention of the increase of exertional blood pressure in patients with borderline essential hypertension. Comparative study of the effects of nifedipine and/or propranolol].
    Pompilian V; Nistorescu D; Dumbravă V
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1986; 38(3):213-8. PubMed ID: 2876475
    [No Abstract]   [Full Text] [Related]  

  • 33. Editorial: New knowledge of benign essential hypertension.
    Laidlaw JC
    Can Med Assoc J; 1973 Sep; 109(6):453 passim. PubMed ID: 4355134
    [No Abstract]   [Full Text] [Related]  

  • 34. [Spironolactone and propranolol in combination therapy of arterial hypertension].
    Di Veroli C; Compagno S; Iugoli AR
    Clin Ter; 1982 Nov; 103(3):283-7. PubMed ID: 7151382
    [No Abstract]   [Full Text] [Related]  

  • 35. [Heart rate and blood pressure under psychological and physical laboratory stress in young hypertensive patients following long-term therapy with the beta receptor blocker propranolol].
    Pietruschka WD; Scheuch K; Gruber G; Tomaschewskaja LI; Reuschel I
    Z Gesamte Inn Med; 1981 Mar; 36(6):218-22. PubMed ID: 7257458
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiovascular response to isometric stress (handgrip) in patients with essential hypertension before and after antihypertensive therapy with propranolol or alpha methyldopa.
    Baldwa VS; Gupta BS; Chittora MD
    Indian Heart J; 1983; 35(6):333-6. PubMed ID: 6667950
    [No Abstract]   [Full Text] [Related]  

  • 37. [Atenolol, pindolol and propranolol in essential hypertension: response rate and tolerance].
    Greminger P; Vetter H; Boerlin HJ; Baumgart P; Havelka J; Walger P; Lüscher T; Siegenthaler W; Vetter W
    Schweiz Med Wochenschr; 1982 Dec; 112(50):1831-5. PubMed ID: 7156966
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of bevantolol and propranolol on serum lipids in patients with essential hypertension.
    Sasaki J; Kajiyama G; Kusukawa R; Mori H; Koga S; Takagi R; Tanaka N; Ogawa N; Arakawa K
    Int J Clin Pharmacol Ther; 1994 Dec; 32(12):660-4. PubMed ID: 7881705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparative effectiveness of various beta adrenergic blockaders in hypertension].
    Povetkin SV
    Sov Med; 1991; (4):94. PubMed ID: 1871651
    [No Abstract]   [Full Text] [Related]  

  • 40. [Ambulatory antihypertensive therapy using the beta-receptor blockader obsidan].
    Dück KD; Knappe J; Strube G
    Z Gesamte Inn Med; 1973 Aug; 28(16):Suppl:248-51. PubMed ID: 4767603
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.